Works matching IS 1358863X AND DT 2005 AND VI 10 AND IP 2S
Results: 15
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S97, doi. 10.1191/1358863x05vm608oa
- By:
- Publication type:
- Article
Calender of events.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S103, doi. 10.1191/1358863x05vm627xx
- Publication type:
- Article
Arginine metabolism in vascular biology and disease.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S83, doi. 10.1191/1358863x05vm601oa
- By:
- Publication type:
- Article
Asymmetric dimethylarginine (ADMA) accelerates cell senescence.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S65, doi. 10.1191/1358863x05vm606oa
- By:
- Publication type:
- Article
ADMA and hyperhomocysteinemia.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S27, doi. 10.1191/1358863x05vm599oa
- By:
- Publication type:
- Article
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S35, doi. 10.1191/1358863x05vm604oa
- By:
- Publication type:
- Article
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S19, doi. 10.1191/1358863x05vm602oa
- By:
- Publication type:
- Article
Spotlight on endothelial progenitor cell inhibitors: short review.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S59, doi. 10.1191/1358863x05vm607oa
- By:
- Publication type:
- Article
DDAH gene and cardiovascular risk.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S45, doi. 10.1191/1358863x05vm600oa
- By:
- Publication type:
- Article
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S49, doi. 10.1191/1358863x05vm605oa
- By:
- Publication type:
- Article
ADMA: its role in vascular disease.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S11, doi. 10.1191/1358863x05vm598oa
- By:
- Publication type:
- Article
ADMA metabolism and clearance.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S73, doi. 10.1191/1358863x05vm597oa
- By:
- Publication type:
- Article
Quantification of ADMA: analytical approaches.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S89, doi. 10.1191/1358863x05vm596oa
- By:
- Publication type:
- Article
Endogenous production of nitric oxide synthase inhibitors.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S3, doi. 10.1191/1358863x05vm595oa
- By:
- Publication type:
- Article
ADMA: an emerging cardiovascular risk factor.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 2S, p. S1, doi. 10.1191/1358863x05vm594ed
- By:
- Publication type:
- Article